|Day Low/High||1.11 / 1.20|
|52 Wk Low/High||1.10 / 2.98|
And Notice Regarding Plaza Centers' Casa Radio Project in Romania
The Swiss drugmaker agreed to take a 15% stake in Gamida Cell, an Israeli developer of stem cell therapies, in a deal that could reach over $600 million.
These under-$10 stocks look ready to trade higher from current levels.
Elbit Imaging (EMITF) is rocketing higher on Tuesday after announcing its Gamida Cell Ltd, which Elbit's subsidiary Elbit Medical Technologies holds 30.8% voting power in, had received an acquisition proposal from a pharmaceutical company.
Shares rise on FDA nod for the company's device to treat uterine fibroids.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.